Literature DB >> 27280684

Distilling complexity to advance cardiac tissue engineering.

Brenda M Ogle1, Nenad Bursac2, Ibrahim Domian3, Ngan F Huang4, Philippe Menasché5, Charles E Murry6, Beth Pruitt7, Milica Radisic8, Joseph C Wu9, Sean M Wu10, Jianyi Zhang11, Wolfram-Hubertus Zimmermann12, Gordana Vunjak-Novakovic13.   

Abstract

The promise of cardiac tissue engineering is in the ability to recapitulate in vitro the functional aspects of a healthy heart and disease pathology as well as to design replacement muscle for clinical therapy. Parts of this promise have been realized; others have not. In a meeting of scientists in this field, five central challenges or "big questions" were articulated that, if addressed, could substantially advance the current state of the art in modeling heart disease and realizing heart repair.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Year:  2016        PMID: 27280684      PMCID: PMC4959426          DOI: 10.1126/scitranslmed.aad2304

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  33 in total

Review 1.  The road to biological pacing.

Authors:  Michael R Rosen; Richard B Robinson; Peter R Brink; Ira S Cohen
Journal:  Nat Rev Cardiol       Date:  2011-08-16       Impact factor: 32.419

2.  Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report.

Authors:  Philippe Menasché; Valérie Vanneaux; Albert Hagège; Alain Bel; Bernard Cholley; Isabelle Cacciapuoti; Alexandre Parouchev; Nadine Benhamouda; Gérard Tachdjian; Lucie Tosca; Jean-Hugues Trouvin; Jean-Roch Fabreguettes; Valérie Bellamy; Romain Guillemain; Caroline Suberbielle Boissel; Eric Tartour; Michel Desnos; Jérôme Larghero
Journal:  Eur Heart J       Date:  2015-05-19       Impact factor: 29.983

3.  Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.

Authors:  Thomas Pilgrim; Dik Heg; Marco Roffi; David Tüller; Olivier Muller; André Vuilliomenet; Stéphane Cook; Daniel Weilenmann; Christoph Kaiser; Peiman Jamshidi; Therese Fahrni; Aris Moschovitis; Stéphane Noble; Franz R Eberli; Peter Wenaweser; Peter Jüni; Stephan Windecker
Journal:  Lancet       Date:  2014-09-01       Impact factor: 79.321

4.  Growth of engineered human myocardium with mechanical loading and vascular coculture.

Authors:  Nathaniel L Tulloch; Veronica Muskheli; Maria V Razumova; F Steven Korte; Michael Regnier; Kip D Hauch; Lil Pabon; Hans Reinecke; Charles E Murry
Journal:  Circ Res       Date:  2011-05-19       Impact factor: 17.367

5.  Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.

Authors:  Ning Sun; Masayuki Yazawa; Jianwei Liu; Leng Han; Veronica Sanchez-Freire; Oscar J Abilez; Enrique G Navarrete; Shijun Hu; Li Wang; Andrew Lee; Aleksandra Pavlovic; Shin Lin; Rui Chen; Roger J Hajjar; Michael P Snyder; Ricardo E Dolmetsch; Manish J Butte; Euan A Ashley; Michael T Longaker; Robert C Robbins; Joseph C Wu
Journal:  Sci Transl Med       Date:  2012-04-18       Impact factor: 17.956

6.  Patching up broken hearts: cardiac cell therapy gets a bioengineered boost.

Authors:  Vahid Serpooshan; Sean M Wu
Journal:  Cell Stem Cell       Date:  2014-12-04       Impact factor: 24.633

7.  Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.

Authors:  Nicola Smart; Catherine A Risebro; Athalie A D Melville; Kelvin Moses; Robert J Schwartz; Kenneth R Chien; Paul R Riley
Journal:  Nature       Date:  2006-11-15       Impact factor: 49.962

8.  Inhibition of β-catenin signaling respecifies anterior-like endothelium into beating human cardiomyocytes.

Authors:  Nathan J Palpant; Lil Pabon; Meredith Roberts; Brandon Hadland; Daniel Jones; Christina Jones; Randall T Moon; Walter L Ruzzo; Irwin Bernstein; Ying Zheng; Charles E Murry
Journal:  Development       Date:  2015-07-07       Impact factor: 6.868

9.  An integrated statistical model for enhanced murine cardiomyocyte differentiation via optimized engagement of 3D extracellular matrices.

Authors:  Jangwook P Jung; Dongjian Hu; Ibrahim J Domian; Brenda M Ogle
Journal:  Sci Rep       Date:  2015-12-21       Impact factor: 4.379

10.  HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy.

Authors:  John T Hinson; Anant Chopra; Navid Nafissi; William J Polacheck; Craig C Benson; Sandra Swist; Joshua Gorham; Luhan Yang; Sebastian Schafer; Calvin C Sheng; Alireza Haghighi; Jason Homsy; Norbert Hubner; George Church; Stuart A Cook; Wolfgang A Linke; Christopher S Chen; J G Seidman; Christine E Seidman
Journal:  Science       Date:  2015-08-28       Impact factor: 47.728

View more
  64 in total

Review 1.  Body builder: from synthetic cells to engineered tissues.

Authors:  Shiqi Hu; Brenda M Ogle; Ke Cheng
Journal:  Curr Opin Cell Biol       Date:  2018-04-25       Impact factor: 8.382

Review 2.  Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling.

Authors:  Joshua Mayourian; Delaine K Ceholski; David M Gonzalez; Timothy J Cashman; Susmita Sahoo; Roger J Hajjar; Kevin D Costa
Journal:  Circ Res       Date:  2018-01-05       Impact factor: 17.367

3.  Temporal Impact of Substrate Anisotropy on Differentiating Cardiomyocyte Alignment and Functionality.

Authors:  Alicia C B Allen; Elissa Barone; Nima Momtahan; Cody O Crosby; Chengyi Tu; Wei Deng; Krista Polansky; Janet Zoldan
Journal:  Tissue Eng Part A       Date:  2019-08-20       Impact factor: 3.845

4.  Inspiration from heart development: Biomimetic development of functional human cardiac organoids.

Authors:  Dylan J Richards; Robert C Coyle; Yu Tan; Jia Jia; Kerri Wong; Katelynn Toomer; Donald R Menick; Ying Mei
Journal:  Biomaterials       Date:  2017-07-12       Impact factor: 12.479

Review 5.  Regulation of the microenvironment for cardiac tissue engineering.

Authors:  Maureen Wanjare; Ngan F Huang
Journal:  Regen Med       Date:  2017-02-17       Impact factor: 3.806

Review 6.  Engineered Heart Repair.

Authors:  B Fujita; W-H Zimmermann
Journal:  Clin Pharmacol Ther       Date:  2017-06-29       Impact factor: 6.875

Review 7.  Decellularized Extracellular Matrix Materials for Cardiac Repair and Regeneration.

Authors:  Donald Bejleri; Michael E Davis
Journal:  Adv Healthc Mater       Date:  2019-02-04       Impact factor: 9.933

8.  Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation.

Authors:  Christopher P Jackman; Asvin M Ganapathi; Huda Asfour; Ying Qian; Brian W Allen; Yanzhen Li; Nenad Bursac
Journal:  Biomaterials       Date:  2018-01-03       Impact factor: 12.479

9.  Engineered human myocardium with local release of angiogenic proteins improves vascularization and cardiac function in injured rat hearts.

Authors:  Fabiola Munarin; Rajeev J Kant; Cassady E Rupert; Amelia Khoo; Kareen L K Coulombe
Journal:  Biomaterials       Date:  2020-04-12       Impact factor: 12.479

10.  N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.

Authors:  Xi Lou; Meng Zhao; Chengming Fan; Vladimir G Fast; Mani T Valarmathi; Wuqiang Zhu; Jianyi Zhang
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.